APO Research
Talk to an analyst

APO RESEARCH · REPORT

Animal Orthopedic Diseases Stem Cell Therapy

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Animal Orthopedic Diseases Stem Cell Therapy Industry Growth and Trends Forecast to 2032

23 December 2025113 pages

Choose your research edition.

Industry ResearchAnimal Orthopedic Diseases Stem Cell Therapy Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal Orthopedic Diseases Stem Cell Therapy Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Animal Orthopedic Diseases Stem Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal Orthopedic Diseases Stem Cell Therapy Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal Orthopedic Diseases Stem Cell Therapy Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

According to APO Research, the global Animal Orthopedic Diseases Stem Cell Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Animal Orthopedic Diseases Stem Cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Animal Orthopedic Diseases Stem Cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Animal Orthopedic Diseases Stem Cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Animal Orthopedic Diseases Stem Cell Therapy market include Vetcell, Tianjin BION Biotechnology, Amazing Pet, Boya Life, ZyGenesis, Vetsuisse, VetStem, Tissue Regeneration and Regeneus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Animal Orthopedic Diseases Stem Cell Therapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Animal Orthopedic Diseases Stem Cell Therapy market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Animal Orthopedic Diseases Stem Cell Therapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Animal Orthopedic Diseases Stem Cell Therapy.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Animal Orthopedic Diseases Stem Cell Therapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Animal Orthopedic Diseases Stem Cell Therapy Market by Company

Vetcell

Tianjin BION Biotechnology

Amazing Pet

Boya Life

ZyGenesis

Vetsuisse

VetStem

Tissue Regeneration

Regeneus

Regenesis Biomedical

Neogen

MediVet Biologics

Kite Pharma

Juno Therapeutics

Cegelec

Boehringer Ingelheim

Astellas Pharma

Aratana Therapeutics

Animal Orthopedic Diseases Stem Cell Therapy Segment by Type

Totipotent Stem Cells

Pluripotent Stem Cells

Unipotent Stem Cells

Animal Orthopedic Diseases Stem Cell Therapy Segment by Application

Cartilage Injury

Spinal Degenerative Diseases

Fracture Repair

Osteoarthritis

Femoral Head Necrosis

Others

Animal Orthopedic Diseases Stem Cell Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Orthopedic Diseases Stem Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Orthopedic Diseases Stem Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Orthopedic Diseases Stem Cell Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Animal Orthopedic Diseases Stem Cell Therapy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Animal Orthopedic Diseases Stem Cell Therapy Market Share by Region (2021-2026) Table 4. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Animal Orthopedic Diseases Stem Cell Therapy Market Share by Region (2027-2032) Table 6. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size Share by Type (2021-2026) Table 9. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size Share Forecasted by Type (2027-2032) Table 11. North America Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size Share by Application (2021-2026) Table 24. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size Share Forecasted by Application (2027-2032) Table 26. North America Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Animal Orthopedic Diseases Stem Cell Therapy Industry Trends Table 37. Animal Orthopedic Diseases Stem Cell Therapy Industry Drivers Table 38. Animal Orthopedic Diseases Stem Cell Therapy Industry Opportunities and Challenges Table 39. Animal Orthopedic Diseases Stem Cell Therapy Industry Restraints Table 40. Global Animal Orthopedic Diseases Stem Cell Therapy Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Animal Orthopedic Diseases Stem Cell Therapy Revenue Market Share by Company (2021-2026) Table 42. Global Animal Orthopedic Diseases Stem Cell Therapy Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Animal Orthopedic Diseases Stem Cell Therapy Key Company Headquarters & Area Served Table 44. Global Animal Orthopedic Diseases Stem Cell Therapy Company, Product Type & Application Table 45. Global Animal Orthopedic Diseases Stem Cell Therapy Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Animal Orthopedic Diseases Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Vetcell Company Information Table 49. Vetcell Business Overview Table 50. Vetcell Animal Orthopedic Diseases Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Vetcell Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio Table 52. Vetcell Recent Development Table 53. Tianjin BION Biotechnology Company Information Table 54. Tianjin BION Biotechnology Business Overview Table 55. Tianjin BION Biotechnology Animal Orthopedic Diseases Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Tianjin BION Biotechnology Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio Table 57. Tianjin BION Biotechnology Recent Development Table 58. Amazing Pet Company Information Table 59. Amazing Pet Business Overview Table 60. Amazing Pet Animal Orthopedic Diseases Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Amazing Pet Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio Table 62. Amazing Pet Recent Development Table 63. Boya Life Company Information Table 64. Boya Life Business Overview Table 65. Boya Life Animal Orthopedic Diseases Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Boya Life Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio Table 67. Boya Life Recent Development Table 68. ZyGenesis Company Information Table 69. ZyGenesis Business Overview Table 70. ZyGenesis Animal Orthopedic Diseases Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. ZyGenesis Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio Table 72. ZyGenesis Recent Development Table 73. Vetsuisse Company Information Table 74. Vetsuisse Business Overview Table 75. Vetsuisse Animal Orthopedic Diseases Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Vetsuisse Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio Table 77. Vetsuisse Recent Development Table 78. VetStem Company Information Table 79. VetStem Business Overview Table 80. VetStem Animal Orthopedic Diseases Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. VetStem Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio Table 82. VetStem Recent Development Table 83. Tissue Regeneration Company Information Table 84. Tissue Regeneration Business Overview Table 85. Tissue Regeneration Animal Orthopedic Diseases Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Tissue Regeneration Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio Table 87. Tissue Regeneration Recent Development Table 88. Regeneus Company Information Table 89. Regeneus Business Overview Table 90. Regeneus Animal Orthopedic Diseases Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Regeneus Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio Table 92. Regeneus Recent Development Table 93. Regenesis Biomedical Company Information Table 94. Regenesis Biomedical Business Overview Table 95. Regenesis Biomedical Animal Orthopedic Diseases Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Regenesis Biomedical Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio Table 97. Regenesis Biomedical Recent Development Table 98. Neogen Company Information Table 99. Neogen Business Overview Table 100. Neogen Animal Orthopedic Diseases Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Neogen Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio Table 102. Neogen Recent Development Table 103. MediVet Biologics Company Information Table 104. MediVet Biologics Business Overview Table 105. MediVet Biologics Animal Orthopedic Diseases Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. MediVet Biologics Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio Table 107. MediVet Biologics Recent Development Table 108. Kite Pharma Company Information Table 109. Kite Pharma Business Overview Table 110. Kite Pharma Animal Orthopedic Diseases Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Kite Pharma Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio Table 112. Kite Pharma Recent Development Table 113. Juno Therapeutics Company Information Table 114. Juno Therapeutics Business Overview Table 115. Juno Therapeutics Animal Orthopedic Diseases Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Juno Therapeutics Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio Table 117. Juno Therapeutics Recent Development Table 118. Cegelec Company Information Table 119. Cegelec Business Overview Table 120. Cegelec Animal Orthopedic Diseases Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Cegelec Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio Table 122. Cegelec Recent Development Table 123. Boehringer Ingelheim Company Information Table 124. Boehringer Ingelheim Business Overview Table 125. Boehringer Ingelheim Animal Orthopedic Diseases Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Boehringer Ingelheim Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio Table 127. Boehringer Ingelheim Recent Development Table 128. Astellas Pharma Company Information Table 129. Astellas Pharma Business Overview Table 130. Astellas Pharma Animal Orthopedic Diseases Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Astellas Pharma Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio Table 132. Astellas Pharma Recent Development Table 133. Aratana Therapeutics Company Information Table 134. Aratana Therapeutics Business Overview Table 135. Aratana Therapeutics Animal Orthopedic Diseases Stem Cell Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Aratana Therapeutics Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio Table 137. Aratana Therapeutics Recent Development Table 138. North America Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Animal Orthopedic Diseases Stem Cell Therapy Market Share by Country (2021-2026) Table 141. North America Animal Orthopedic Diseases Stem Cell Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Animal Orthopedic Diseases Stem Cell Therapy Market Share Forecast by Country (2027-2032) Table 143. Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Animal Orthopedic Diseases Stem Cell Therapy Market Share by Country (2021-2026) Table 146. Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Animal Orthopedic Diseases Stem Cell Therapy Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Share by Country (2021-2026) Table 151. Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Share Forecast by Country (2027-2032) Table 153. Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Share by Country (2021-2026) Table 156. Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Share by Country (2021-2026) Table 161. Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Animal Orthopedic Diseases Stem Cell Therapy Product Image Figure 3. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 5. Global Animal Orthopedic Diseases Stem Cell Therapy Market Share by Region: 2025 VS 2032 Figure 6. Global Animal Orthopedic Diseases Stem Cell Therapy Market Share by Region (2021-2032) Figure 7. North America Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Totipotent Stem Cells Image Figure 13. Global Totipotent Stem Cells Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Pluripotent Stem Cells Image Figure 15. Global Pluripotent Stem Cells Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Unipotent Stem Cells Image Figure 17. Global Unipotent Stem Cells Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Animal Orthopedic Diseases Stem Cell Therapy Market Share by Type 2025 VS 2032 Figure 20. North America Animal Orthopedic Diseases Stem Cell Therapy Market Size Share by Type (2021-2032) Figure 21. Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size Share by Type (2021-2032) Figure 23. Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size Share by Type (2021-2032) Figure 25. Cartilage Injury Image Figure 26. Global Cartilage Injury Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Spinal Degenerative Diseases Image Figure 28. Global Spinal Degenerative Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Fracture Repair Image Figure 30. Global Fracture Repair Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Osteoarthritis Image Figure 32. Global Osteoarthritis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Femoral Head Necrosis Image Figure 34. Global Femoral Head Necrosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Others Image Figure 36. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Animal Orthopedic Diseases Stem Cell Therapy Market Share by Application 2025 VS 2032 Figure 39. North America Animal Orthopedic Diseases Stem Cell Therapy Market Size Share by Application (2021-2032) Figure 40. Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size Share by Application (2021-2032) Figure 42. Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 Animal Orthopedic Diseases Stem Cell Therapy Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America Animal Orthopedic Diseases Stem Cell Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America Animal Orthopedic Diseases Stem Cell Therapy Market Share by Country (2021-2032) Figure 49. Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Animal Orthopedic Diseases Stem Cell Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Animal Orthopedic Diseases Stem Cell Therapy Market Share by Country (2021-2032) Figure 52. Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Share by Country (2021-2032) Figure 55. Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Share by Country (2021-2032) Figure 58. Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • Totipotent Stem Cells
  • Pluripotent Stem Cells
  • Unipotent Stem Cells
Applications
  • Cartilage Injury
  • Spinal Degenerative Diseases
  • Fracture Repair
  • Osteoarthritis
  • Femoral Head Necrosis
  • Others
Companies covered
  • Vetcell
  • Tianjin BION Biotechnology
  • Amazing Pet
  • Boya Life
  • ZyGenesis
  • Vetsuisse
  • VetStem
  • Tissue Regeneration
  • Regeneus
  • Regenesis Biomedical
  • Neogen
  • MediVet Biologics
  • Kite Pharma
  • Juno Therapeutics
  • Cegelec
  • Boehringer Ingelheim
  • Astellas Pharma
  • Aratana Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Animal Orthopedic Diseases Stem Cell Therapy Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Animal Orthopedic Diseases Stem Cell Therapy Market Size by Region (2021-2032)
  5. 1.4.1 Global Animal Orthopedic Diseases Stem Cell Therapy Market Size by Region (2021-2026)
  6. 1.4.2 Global Animal Orthopedic Diseases Stem Cell Therapy Market Size by Region (2027-2032)
  7. 1.5 Key Regions Animal Orthopedic Diseases Stem Cell Therapy Market Size (2021-2032)
  8. 1.5.1 North America Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate (2021-2032)
2 Animal Orthopedic Diseases Stem Cell Therapy Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Totipotent Stem Cells
  3. 2.1.2 Pluripotent Stem Cells
  4. 2.1.3 Unipotent Stem Cells
  5. 2.2 Global Animal Orthopedic Diseases Stem Cell Therapy Market Size by Type
  6. 2.2.1 Global Animal Orthopedic Diseases Stem Cell Therapy Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Animal Orthopedic Diseases Stem Cell Therapy Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Animal Orthopedic Diseases Stem Cell Therapy Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Animal Orthopedic Diseases Stem Cell Therapy Market Size by Regions
  10. 2.3.1 North America Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Type (2021-2026)
3 Animal Orthopedic Diseases Stem Cell Therapy Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Cartilage Injury
  3. 3.1.2 Spinal Degenerative Diseases
  4. 3.1.3 Fracture Repair
  5. 3.1.4 Osteoarthritis
  6. 3.1.5 Femoral Head Necrosis
  7. 3.1.6 Others
  8. 3.2 Global Animal Orthopedic Diseases Stem Cell Therapy Market Size by Application
  9. 3.2.1 Global Animal Orthopedic Diseases Stem Cell Therapy Market Size Overview by Application (2021-2032)
  10. 3.2.2 Global Animal Orthopedic Diseases Stem Cell Therapy Historic Market Size Review by Application (2021-2026)
  11. 3.2.3 Global Animal Orthopedic Diseases Stem Cell Therapy Market Size Forecasted by Application (2027-2032)
  12. 3.3 Global Animal Orthopedic Diseases Stem Cell Therapy Market Size by Regions
  13. 3.3.1 North America Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Application (2021-2026)
  14. 3.3.2 Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Application (2021-2026)
  15. 3.3.3 Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Application (2021-2026)
  16. 3.3.4 South America Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Application (2021-2026)
  17. 3.3.5 Middle East and Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Animal Orthopedic Diseases Stem Cell Therapy Industry Trends
  2. 4.2 Animal Orthopedic Diseases Stem Cell Therapy Industry Drivers
  3. 4.3 Animal Orthopedic Diseases Stem Cell Therapy Industry Opportunities and Challenges
  4. 4.4 Animal Orthopedic Diseases Stem Cell Therapy Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Animal Orthopedic Diseases Stem Cell Therapy Revenue (2021-2026)
  2. 5.2 Global Animal Orthopedic Diseases Stem Cell Therapy Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Animal Orthopedic Diseases Stem Cell Therapy Key Company Headquarters & Area Served
  4. 5.4 Global Animal Orthopedic Diseases Stem Cell Therapy Company, Product Type & Application
  5. 5.5 Global Animal Orthopedic Diseases Stem Cell Therapy Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Animal Orthopedic Diseases Stem Cell Therapy Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Animal Orthopedic Diseases Stem Cell Therapy Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Animal Orthopedic Diseases Stem Cell Therapy Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Vetcell
  2. 6.1.1 Vetcell Company Information
  3. 6.1.2 Vetcell Business Overview
  4. 6.1.3 Vetcell Animal Orthopedic Diseases Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Vetcell Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio
  6. 6.1.5 Vetcell Recent Developments
  7. 6.2 Tianjin BION Biotechnology
  8. 6.2.1 Tianjin BION Biotechnology Company Information
  9. 6.2.2 Tianjin BION Biotechnology Business Overview
  10. 6.2.3 Tianjin BION Biotechnology Animal Orthopedic Diseases Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Tianjin BION Biotechnology Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio
  12. 6.2.5 Tianjin BION Biotechnology Recent Developments
  13. 6.3 Amazing Pet
  14. 6.3.1 Amazing Pet Company Information
  15. 6.3.2 Amazing Pet Business Overview
  16. 6.3.3 Amazing Pet Animal Orthopedic Diseases Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Amazing Pet Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio
  18. 6.3.5 Amazing Pet Recent Developments
  19. 6.4 Boya Life
  20. 6.4.1 Boya Life Company Information
  21. 6.4.2 Boya Life Business Overview
  22. 6.4.3 Boya Life Animal Orthopedic Diseases Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Boya Life Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio
  24. 6.4.5 Boya Life Recent Developments
  25. 6.5 ZyGenesis
  26. 6.5.1 ZyGenesis Company Information
  27. 6.5.2 ZyGenesis Business Overview
  28. 6.5.3 ZyGenesis Animal Orthopedic Diseases Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 ZyGenesis Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio
  30. 6.5.5 ZyGenesis Recent Developments
  31. 6.6 Vetsuisse
  32. 6.6.1 Vetsuisse Company Information
  33. 6.6.2 Vetsuisse Business Overview
  34. 6.6.3 Vetsuisse Animal Orthopedic Diseases Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Vetsuisse Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio
  36. 6.6.5 Vetsuisse Recent Developments
  37. 6.7 VetStem
  38. 6.7.1 VetStem Company Information
  39. 6.7.2 VetStem Business Overview
  40. 6.7.3 VetStem Animal Orthopedic Diseases Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 VetStem Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio
  42. 6.7.5 VetStem Recent Developments
  43. 6.8 Tissue Regeneration
  44. 6.8.1 Tissue Regeneration Company Information
  45. 6.8.2 Tissue Regeneration Business Overview
  46. 6.8.3 Tissue Regeneration Animal Orthopedic Diseases Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Tissue Regeneration Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio
  48. 6.8.5 Tissue Regeneration Recent Developments
  49. 6.9 Regeneus
  50. 6.9.1 Regeneus Company Information
  51. 6.9.2 Regeneus Business Overview
  52. 6.9.3 Regeneus Animal Orthopedic Diseases Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Regeneus Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio
  54. 6.9.5 Regeneus Recent Developments
  55. 6.10 Regenesis Biomedical
  56. 6.10.1 Regenesis Biomedical Company Information
  57. 6.10.2 Regenesis Biomedical Business Overview
  58. 6.10.3 Regenesis Biomedical Animal Orthopedic Diseases Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Regenesis Biomedical Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio
  60. 6.10.5 Regenesis Biomedical Recent Developments
  61. 6.11 Neogen
  62. 6.11.1 Neogen Company Information
  63. 6.11.2 Neogen Business Overview
  64. 6.11.3 Neogen Animal Orthopedic Diseases Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Neogen Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio
  66. 6.11.5 Neogen Recent Developments
  67. 6.12 MediVet Biologics
  68. 6.12.1 MediVet Biologics Company Information
  69. 6.12.2 MediVet Biologics Business Overview
  70. 6.12.3 MediVet Biologics Animal Orthopedic Diseases Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 MediVet Biologics Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio
  72. 6.12.5 MediVet Biologics Recent Developments
  73. 6.13 Kite Pharma
  74. 6.13.1 Kite Pharma Company Information
  75. 6.13.2 Kite Pharma Business Overview
  76. 6.13.3 Kite Pharma Animal Orthopedic Diseases Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Kite Pharma Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio
  78. 6.13.5 Kite Pharma Recent Developments
  79. 6.14 Juno Therapeutics
  80. 6.14.1 Juno Therapeutics Company Information
  81. 6.14.2 Juno Therapeutics Business Overview
  82. 6.14.3 Juno Therapeutics Animal Orthopedic Diseases Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Juno Therapeutics Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio
  84. 6.14.5 Juno Therapeutics Recent Developments
  85. 6.15 Cegelec
  86. 6.15.1 Cegelec Company Information
  87. 6.15.2 Cegelec Business Overview
  88. 6.15.3 Cegelec Animal Orthopedic Diseases Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Cegelec Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio
  90. 6.15.5 Cegelec Recent Developments
  91. 6.16 Boehringer Ingelheim
  92. 6.16.1 Boehringer Ingelheim Company Information
  93. 6.16.2 Boehringer Ingelheim Business Overview
  94. 6.16.3 Boehringer Ingelheim Animal Orthopedic Diseases Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Boehringer Ingelheim Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio
  96. 6.16.5 Boehringer Ingelheim Recent Developments
  97. 6.17 Astellas Pharma
  98. 6.17.1 Astellas Pharma Company Information
  99. 6.17.2 Astellas Pharma Business Overview
  100. 6.17.3 Astellas Pharma Animal Orthopedic Diseases Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Astellas Pharma Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio
  102. 6.17.5 Astellas Pharma Recent Developments
  103. 6.18 Aratana Therapeutics
  104. 6.18.1 Aratana Therapeutics Company Information
  105. 6.18.2 Aratana Therapeutics Business Overview
  106. 6.18.3 Aratana Therapeutics Animal Orthopedic Diseases Stem Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Aratana Therapeutics Animal Orthopedic Diseases Stem Cell Therapy Product Portfolio
  108. 6.18.5 Aratana Therapeutics Recent Developments
7 North America
  1. 7.1 North America Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2021-2026)
  3. 7.3 North America Animal Orthopedic Diseases Stem Cell Therapy Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2021-2026)
  3. 8.3 Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2021-2026)
  3. 10.3 South America Animal Orthopedic Diseases Stem Cell Therapy Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst